11/19/2013

Biohit Oyj

Biohit Launches a New Quick Test

Biohit Oyj has launched a diagnostic quick test, which allows the diagnosis of celiac disease from fingertip blood sample. Celiac disease is relatively common autoimmune disease in which the rye, wheat and barley protein (gluten) causes inflammation and damage of intestinal mucosa, which interferes with the absorption of nutrients. Quick test developed by Biohit confirms the diagnosis from a fingertip blood sample within ten minutes.


Celiac quick test broadens the spectrum of Biohit’s diagnostic quick tests. The new test is CE-IVD registered and at the time of market entry available in European countries.


Medical Director of Biohit Oyj, professor Kari Syrjänen, MD, Ph.D., FIAC: "Quick test is an efficient method to diagnose celiac disease. The test measures gluten antibodies in serum and negative results exclude celiac disease. Compared to endoscopy, fingertip blood test is a much more pleasant way to make the diagnosis."


CEO Semi Korpela, Biohit Oyj: "The new test is simple, fast and reliable. The test will bring clear benefits in healthcare costs, because it reduces the number of unnecessary endoscopies. Quick test cost is a fraction compared to conventional diagnosis by endoscopic biopsy. "


 


Additional information:


CEO Semi Korpela, Biohit Oyj Tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com


 


This news release was distributed by GlobeNewswire, www.globenewswire.com – a NASDAQ OMX company